NCT07196176|Recruiting
Electrophysiological Registry Duesseldorf
Registry on Electrophysiological Studies (EPS) at University Hospital Düsseldorf
Loading search results
Registry on Electrophysiological Studies (EPS) at University Hospital Düsseldorf
Sponsor study identifier
observational
1,000
1 country
1
Study Start
June 1, 2019
Actual (reported)Primary Completion
December 31, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 31, 2031
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This registry at University Hospital Düsseldorf collects retrospective and prospective (from 2019 onward) data on patients undergoing electrophysiological studies (EPS), catheter ablation, and electrical cardioversion. The primary goal is to evaluate safety, efficacy, and clinical outcomes of these standard procedures in routine care. Data will be used for quality assurance and to identify prognostic patient- and procedure-related factors.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2031
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 1, 2019
Actual (reported)September 17, 2025
Actual (reported)September 29, 2025
Actual (reported)December 31, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 31, 2031
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Periprocedural and postprocedural safety events
All cardiovascular adverse events or complications occurring during hospitalization and late complications after discharge related to EPS, ablation, or electrical cardioversion.
Up to 24 months after procedure
Clinical efficacy outcomes
Procedural success, recurrence of arrhythmias or symptoms, and need for repeat EPS/cardioversion, additional medication, or device implantation (e.g., pacemaker).
Up to 24 months after procedure
All-cause mortality
Up to 24 months after procedure
Patients with heart rhythm disorders
University Hospital Duesseldorf
Düsseldorf, 40225, Germany
Plasma
Malte Kelm, MD
Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf
Obaida Rana, MD
Division of Cardiology, Pulmonary Disease and Vascular Medicine at University Hospital Duesseldorf
First Submitted
September 17, 2025
First Posted
September 29, 2025
Study Start
June 1, 2019
Actual (reported)Primary Completion
December 31, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
ArcticLine Feasibility Study
All-cause hospitalization
Up to 24 months after procedure
Contact the study team to confirm eligibility.
Study Completion
December 31, 2031
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
September 29, 2025
Record last verified: 2025-09
not necessary as its a registry
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: